%0 Journal Article %A Savas Ozsu %A Hayriye Bektas %A Yasin Abul %A Tevfik Ozlü %T Combination of sPESI and cardiac troponin in the outpatient treatment of pulmoner thromboembolism %D 2014 %J European Respiratory Journal %P P2391 %V 44 %N Suppl 58 %X It is controversial that which patients will be taken outcome treatment in pulmonary thromboembolism. Our aim is determinantion of outpatients using sPESI and cardiac troponin in pulmonary thromboembolism.The study was performed prospectively between 02.04.2012 and 13.09.2013. Malignite was excluded from the score of sPESI. Patients seperated into four groups according to troponin and sPESI. Group-1 was consisted with low troponin and low-risk sPESI; group-2 was negative troponin and high-risk sPESI; group-3 was high troponin and low-risk sPESI; grup-4 was high troponin and high-risk sPESI. Primary outcome was defined as all cause of mortality within 90 days. Secondary outcome was defined as recurrens or nonfatal bleeding. Patients in group-1 were treated as outpatient. Upper limit of troponin was considered as 0,04.In our study there were 138 patients with pulmonary thromboembolism. There were 36 (%26,1) patients in group-1; 42 (%30,4) patients in group-2; 4 (%2,9) patients in group-3; 56 (%40,6) patients in group-4. There were 19 (%13,8) patients treated as outpatient . The patients %5,7 of group-1; %18,6 of group-2; %50 of group-3 and %53,6 of group-4 were died within 90 days. There were detected recurrens or nonfatal bleeding within 90 days of the patients %8,6 of group-1; %6,9 of group-2 ; %25 of group-3 and %16,1 of group-4. As a result of patients with low risk sPESI and negative troponin are thought to be safely treated as outpatients. %U